"Futa" inamaanisha nini?
Mnyama hana kubeba mabadiliko. Haitaendeleza ugonjwa huo na hataipitisha.
Discover the importance of the DNA test for Bernard-Soulier Syndrome (BSS-C) in dogs, a rare genetic disorder affecting platelet function and blood clotting. Early detection through this specialized DNA test helps breeders and veterinarians identify carriers and affected dogs, preventing the spread of BSS-C in breeding lines. By understanding your dog's genetic status, you can make informed decisions to ensure healthier litters and improve overall canine health. Our accurate and reliable Bernard-Soulier Syndrome DNA test offers peace of mind for responsible dog owners. Protect your dog's future with advanced genetic screening today. Stay proactive in managing hereditary conditions with our expert testing services.
Bernard-Soulier Syndrome (BSS-C) in dogs is a rare inherited bleeding disorder caused by a genetic mutation affecting platelet function. DNA testing can identify carriers and affected dogs by detecting mutations in the GP1b gene complex. Early diagnosis through genetic screening helps breeders avoid producing affected puppies. This test is crucial for managing the health of at-risk breeds. Understanding BSS-C at the DNA level supports better treatment and prevention strategies.
Jaribio hili la DNA limejumuishwa kuanzia kwenye pakiti yetu Basic - na pia ni sehemu ya vifurushi Basic, Standard, Advanced, Complete.
Tazama Vifurushi vya Uchunguzi wa DNA →Bernard-Soulier Syndrome (BSS-C) is a rare genetic disorder that affects blood clotting in dogs. This condition is characterized by a deficiency in the glycoprotein complex known as GPIb-IX-V, which plays a crucial role in platelet function and adhesion. As a result, dogs with BSS-C experience abnormal bleeding due to their platelets' inability to effectively bind to blood vessel walls, leading to a compromised hemostatic response.
BSS-C is inherited in an autosomal recessive manner, meaning that both copies of the gene involved must be mutated for the disease to manifest. The specific genetic mutations associated with BSS-C can be identified through DNA testing, allowing for the detection of carriers and affected individuals. Understanding the genetic basis of this condition is essential for breeding programs aimed at reducing the prevalence of BSS-C in canine populations.
Dogs affected by BSS-C may display various clinical signs that are primarily related to bleeding disorders. Common symptoms include prolonged bleeding from cuts or surgical sites, spontaneous nosebleeds, and the presence of bruises or petechiae (small red or purple spots on the skin). In more severe cases, internal bleeding can occur, which may lead to serious health complications. Early recognition and management of these symptoms are crucial for the welfare of affected dogs.
Diagnosis of Bernard-Soulier Syndrome typically involves a combination of clinical evaluation and laboratory testing. A veterinarian may observe the clinical signs and recommend blood tests to assess platelet function and count. Furthermore, DNA testing can confirm the diagnosis by identifying mutations in the genes associated with the syndrome. This comprehensive approach ensures accurate identification of the condition and aids in appropriate management strategies.
While there is no cure for Bernard-Soulier Syndrome, management strategies can help mitigate the risks associated with the condition. Supportive care may include avoiding situations that could lead to injury or bleeding. In cases of significant bleeding, veterinary intervention may be necessary, which can include blood transfusions or other therapeutic measures to stabilize the dog’s condition. Regular veterinary check-ups and monitoring are essential for managing the health of affected dogs.
Bernard-Soulier Syndrome is a significant genetic disorder that affects the hemostatic function in dogs, leading to a predisposition to bleeding. Through DNA testing, early diagnosis and management can be achieved, improving the quality of life for affected individuals. Awareness and understanding of this condition are vital for dog owners, breeders, and veterinarians alike.
Mnyama hana kubeba mabadiliko. Haitaendeleza ugonjwa huo na hataipitisha.
Hapana. Kwa ujumla mnyama huyo ana afya nzuri lakini anaweza kupitisha mabadiliko hayo uzao.
Inabeba nakala mbili zilizobadilishwa. Ishara za kliniki zinatarajiwa kulingana na ugonjwa huo. Haipaswi kufugwa.
Baadhi ya magonjwa yanahusishwa na ngono, hivyo kujieleza kwao hutofautiana kulingana na ngono ya mnyama.
This DNA test detects the mutation associated with Bernard-Soulier Syndrome (BSS-C) in order to identify clear, carrier, or at-risk animals.
Upimaji wa DNA huwasaidia wafugaji kupanga uzazi salama na kupunguza hatari ya kusambaza mabadiliko hayo kwa watoto.
Hali ya urithi iliyoripotiwa kwa jaribio hili ni Autosomal Recessive.
This test analyses the mutation GP9 c.127_*2052del.
Si lazima. Ufafanuzi unategemea muundo wa urithi na genotype inayotokana.
Gentilini Fabio, Turba Maria Elena, Giancola Fiorella, Chiocchetti Roberto, Bernardini Chiara, Dajbychova Markéta, Jagannathan Vidhya, Drögemüller Michaela, Drögemüller Cord. A large deletion in the GP9 gene in Cocker Spaniel dogs with Bernard-Soulier syndrome. PLoS One. 2019 Sep 4;14(9):e0220625. doi: 10.1371/journal.pone.0220625. eCollection 2019.
Faragha yako, chaguo lako
Tunatumia vidakuzi muhimu kuendesha tovuti. Vidakuzi vya hiari (kama vile watoa huduma wa maudhui waliopachikwa) huzimwa kwa chaguomsingi na huwashwa tu ikiwa unakubali. Unaweza kubadilisha chaguo lako wakati wowote kwa kutumia kitufe cha "Vidakuzi".
Inahitajika kwa vipengele vya msingi na usalama. Imewashwa kila wakati.
Huboresha vipengele kama vile uwekaji mapendeleo au upachikaji usio wa utangazaji.
Inatusaidia kuelewa matumizi ya tovuti. Imezimwa kwa chaguomsingi.
Kutangaza/kufuatilia kwenye tovuti (baadhi ya vipachiko vya video/ramani). Imezimwa kwa chaguomsingi.